Congress Improving Seniors’ Timely Access to Care Act of 2022 Entering Markup Phase Thomas Sullivan Aug 8, 2022 0 In late July 2022, the United States House of Representatives Ways and Means Committee marked up H.R. 8487, the Improving Seniors’…
DOJ Biotronik Reaches Nearly $13 Million Settlement with DOJ Over Alleged False… Thomas Sullivan Aug 5, 2022 0 On July 22, 2022, the United States Department of Justice (DOJ) announced a $12.95 million settlement with Biotronik Inc., a…
CMS CMS Announces Enhancing Oncology Model Successor to Oncology Care Model Thomas Sullivan Aug 4, 2022 0 In June, the Centers for Medicare & Medicaid Services (CMS) announced the Enhancing Oncology Model, a successor to the…
CMS CMS and FDA Show United Front on Aduhelm Approval and Coverage Thomas Sullivan Aug 3, 2022 0 Earlier this year, Centers for Medicare and Medicaid Services (CMS) Administrator Chiquita Brooks-LaSure and Food and Drug…
Drug Prices Report Finds that Branded Drug Prices Increased an Average of 5% Last Year Thomas Sullivan Aug 2, 2022 0 Earlier this year, Iqvia released a report, The Use of Medicines in the U.S. 2022, which outlined some of the usage and spending…
Medical Legal Court Rules in Favor of Three Major Opioid Distributors in West Virginia… Thomas Sullivan Aug 1, 2022 0 On Monday, July 4, 2022, United States District Court Judge David Faber ruled in favor of three opioid distributors – Amerisource…
Editorials Analysis of Drug Formulary Exclusions from the Patient’s Perspective Thomas Sullivan Jul 29, 2022 0 Earlier this year, Robert Popovian, Pharm.D.; Anne M. Sydor, Ph.D.; and Peter Pitts conducted an analysis of drug formulary…
CMS CMS Issues First Fines to Non-Compliant Hospitals Under Price Transparency… Thomas Sullivan Jul 28, 2022 0 On June 7, 2022, the Centers for Medicare and Medicaid Services (CMS) issued the first fines with respect to the transparency…
CME HHS OIG Issues Advisory Opinion on Continuing Medical Education, Stark Law… Thomas Sullivan Jul 27, 2022 0 In June 2022, the United States Department of Health and Human Services Office of Inspector General (HHS OIG) released OIG…
FDA FDA Releases Draft Guidance on Benefit-Risk Principles Thomas Sullivan Jul 26, 2022 0 On May 10, 2022, FDA published draft guidance entitled, “Benefit-Risk Considerations for Product Quality Assessments”, which…